Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Más filtros










Base de datos
Intervalo de año de publicación
1.
Int J Sports Med ; 37(13): 1073-1079, 2016 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-27676142

RESUMEN

It remains unknown whether or not a reduction in muscle sympathetic nerve activity in heart failure patients is associated over time with the effects of long- or short-term repeated exercise. 10 chronic heart failure patients, age 49±3 years old, functional class I-III NYHA, ejection fraction <40% were randomly submitted to either an acute bout of moderate continuous exercise OR high-intensity interval exercise. Muscle sympathetic nerve activity (microneurography) and forearm blood flow (venous occlusion plethysmography) were evaluated pre- and post-exercise sessions. The moderate exercise consisted of cycle exercise at an intensity corresponding to anaerobic threshold. The interval exercise consisted of a 2-min cycle exercise at intensity corresponding to anaerobic threshold, followed by a 1-min exercise set at respiratory compensation point. Exercise capacity was evaluated by cardiopulmonary exercise test. The caloric expenditure in both sessions was 100 kcal. Baseline muscle sympathetic nerve activity and forearm blood flow levels were not different between sessions. Moderate or high-intensity exercise caused no significant changes in muscle sympathetic nerve activity and forearm blood flow. These findings suggest that the reduction in muscle sympathetic nerve activity and the increase in forearm blood flow provoked by exercise training in chronic heart failure patients are due to cumulative effects over time.


Asunto(s)
Ejercicio Físico/fisiología , Insuficiencia Cardíaca/fisiopatología , Músculo Esquelético/inervación , Sistema Nervioso Simpático/fisiopatología , Enfermedad Crónica , Prueba de Esfuerzo , Femenino , Antebrazo/irrigación sanguínea , Entrenamiento de Intervalos de Alta Intensidad , Humanos , Masculino , Microelectrodos , Persona de Mediana Edad , Pletismografía , Flujo Sanguíneo Regional
2.
Int J Sports Med ; 34(10): 931-5, 2013 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-23606338

RESUMEN

Previous study showed that muscle sympathetic nerve activity (MSNA) was augmented in anabolic steroids users (AASU). In the present study, we tested the hypothesis that the heart rate (HR) responses after maximal exercise testing would be reduced in AASU. 10 male AASU and 10 AAS nonusers (AASNU) were studied. Cardiopulmonary exercise was performed to assess the functional capacity and heart rate recovery. MSNA was recorded directly from the peroneal nerve by microneurography technique. Peak oxygen consumption (VO2) was lower in AASU compared to AASNU (43.66±2.24 vs. 52.70±1.68 ml/kg/min, P=0.005). HR recovery (HRR) at first and second minute was lower in AASU than AASNU (21±2 vs. 27±2 bpm, P=0.02 and 37±4 vs. 45±2 bpm, P=0.05, respectively). MSNA was higher in AASU than AASNU (29±3 vs. 20±1 bursts/min, P=0.01). Further analysis showed a correlation between HRR and MSNA (r=- 0.64, P=0.02), HRR at first minute and peak VO2 (r=0.70, P=0.01) and HRR at second minute and peak VO2 (r=0.62, P=0.02). The exacerbated sympathetic outflow associated with a lower parasympathetic activation after maximal exercise, which impairs heart rate recovery, strengthens the idea of autonomic imbalance in AASU.


Asunto(s)
Anabolizantes/efectos adversos , Andrógenos/efectos adversos , Ejercicio Físico/fisiología , Frecuencia Cardíaca/efectos de los fármacos , Adulto , Prueba de Esfuerzo , Tolerancia al Ejercicio/efectos de los fármacos , Tolerancia al Ejercicio/fisiología , Frecuencia Cardíaca/fisiología , Humanos , Masculino , Consumo de Oxígeno/efectos de los fármacos , Entrenamiento de Fuerza , Autoadministración , Sistema Nervioso Simpático/efectos de los fármacos
3.
Hypertension ; 60(3): 669-76, 2012 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-22802226

RESUMEN

We described recently that systemic hypoxia provokes vasoconstriction in heart failure (HF) patients. We hypothesized that either the exaggerated muscle sympathetic nerve activity and/or endothelial dysfunction mediate the blunted vasodilatation during hypoxia in HF patients. Twenty-seven HF patients and 23 age-matched controls were studied. Muscle sympathetic nerve activity was assessed by microneurography and forearm blood flow (FBF) by venous occlusion plethysmography. Peripheral chemoreflex control was evaluated through the inhaling of a hypoxic gas mixture (10% O(2) and 90% N(2)). Basal muscle sympathetic nerve activity was greater and basal FBF was lower in HF patients versus controls. During hypoxia, muscle sympathetic nerve activity responses were greater in HF patients, and forearm vasodilatation in HF was blunted versus controls. Phentolamine increased FBF responses in both groups, but the increase was lower in HF patients. Phentolamine and N(G)-monomethyl-l-arginine infusion did not change FBF responses in HF but markedly blunted the vasodilatation in controls. FBF responses to hypoxia in the presence of vitamin C were unchanged and remained lower in HF patients versus controls. In conclusion, muscle vasoconstriction in response to hypoxia in HF patients is attributed to exaggerated reflex sympathetic nerve activation and blunted endothelial function (NO activity). We were unable to identify a role for oxidative stress in these studies.


Asunto(s)
Células Quimiorreceptoras/fisiología , Insuficiencia Cardíaca/patología , Insuficiencia Cardíaca/fisiopatología , Músculo Liso Vascular/inervación , Músculo Liso Vascular/fisiología , Flujo Sanguíneo Regional/fisiología , Vasodilatación/fisiología , Adulto , Ácido Ascórbico/farmacología , Estudios de Casos y Controles , Antebrazo/irrigación sanguínea , Hemodinámica/fisiología , Humanos , Hipoxia/fisiopatología , Persona de Mediana Edad , Estrés Oxidativo/fisiología , Fentolamina/farmacología , Sistema Nervioso Simpático/fisiopatología , Vasoconstricción/efectos de los fármacos , Vasoconstricción/fisiología , Vasodilatación/efectos de los fármacos , omega-N-Metilarginina/farmacología
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...